These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9390776)

  • 21. Age-related changes on MAO in Bl/C57 mouse tissues: a quantitative radioautographic study.
    Saura J; Richards JG; Mahy N
    J Neural Transm Suppl; 1994; 41():89-94. PubMed ID: 7931270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings.
    Henriot S; Kuhn C; Kettler R; Da Prada M
    J Neural Transm Suppl; 1994; 41():321-5. PubMed ID: 7931245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
    Hosseini AR; Jackman GP; King PR; Louis WJ; Gundlach AL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):129-36. PubMed ID: 9851561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activity of MAO A and B in rat renal cells and tubules.
    Guimarães JT; Soares-da-Silva P
    Life Sci; 1998; 62(8):727-37. PubMed ID: 9489509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular neuroanatomy of MAO-A and MAO-B.
    Saura Marti J; Kettler R; Da Prada M; Richards JG
    J Neural Transm Suppl; 1990; 32():49-53. PubMed ID: 2089112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327.
    Bench CJ; Price GW; Lammertsma AA; Cremer JC; Luthra SK; Turton D; Dolan RJ; Kettler R; Dingemanse J; Da Prada M
    Eur J Clin Pharmacol; 1991; 40(2):169-73. PubMed ID: 1906004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B.
    Cesura AM; Galva MD; Imhof R; Kyburz E; Picotti GB; Da Prada M
    Eur J Pharmacol; 1989 Mar; 162(3):457-65. PubMed ID: 2744079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics of lazabemide, a reversible and selective inhibitor of monoamine oxidase B.
    Holford NH; Guentert TW; Dingemanse J; Kettler R
    Br J Clin Pharmacol; 1994 Jun; 37(6):553-7. PubMed ID: 7917773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related increases in brain monoamine oxidase B in living healthy human subjects.
    Fowler JS; Volkow ND; Wang GJ; Logan J; Pappas N; Shea C; MacGregor R
    Neurobiol Aging; 1997; 18(4):431-5. PubMed ID: 9330975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.
    Gulyás B; Pavlova E; Kása P; Gulya K; Bakota L; Várszegi S; Keller E; Horváth MC; Nag S; Hermecz I; Magyar K; Halldin C
    Neurochem Int; 2011 Jan; 58(1):60-8. PubMed ID: 21075154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex.
    Kornhuber J; Konradi C; Mack-Burkhardt F; Riederer P; Heinsen H; Beckmann H
    Brain Res; 1989 Oct; 499(1):81-6. PubMed ID: 2804672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Dec; 113(4):1269-74. PubMed ID: 7889283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase.
    Zhou S; Chen G; Huang G
    Bioorg Med Chem; 2018 Sep; 26(17):4863-4870. PubMed ID: 30143367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific binding of [3H]Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling for age at death.
    Ballesteros J; Maeztu AI; Callado LF; Meana JJ; Gutiérrez M
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):55-61. PubMed ID: 17570647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAO-B inhibition in rabbit tissues and in human platelets by Ro 19-6327 shows similar time-course.
    Kettler R; Cesura AM; Dingemanse J; Da Prada M
    J Neural Transm Suppl; 1990; 32():211-4. PubMed ID: 2089093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional action of brofaromine on rat brain MAO-A and MAO-B.
    Gerardy J; Dresse A
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1141-55. PubMed ID: 9829294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Age changes in brain monoamine oxidase in mice from four lines].
    Voĭtenko NN
    Vopr Med Khim; 1992; 38(3):32-5. PubMed ID: 1413646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine oxidase B inhibitor, selegiline, reduces
    Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential changes in monoamine oxidase A and B activity in the aging rat brain.
    Benedetti MS; Keane PE
    J Neurochem; 1980 Nov; 35(5):1026-32. PubMed ID: 7452302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine oxidase isoenzymes in rat brain: differential changes during postnatal development but not aging.
    Rao K; Nagendra SN; Subhash MN
    Neurobiol Aging; 1995; 16(5):833-6. PubMed ID: 8532118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.